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ABSTRACT
Malaria caused by Plasmodium falciparum remains the major life-threatening parasitic infection in the
world. The number of cases in non-endemic countries continues to increase, and it is important that
misdiagnosis of malaria should not occur, especially in non-immune travellers, because of the high risk
of a fatal outcome. In a retrospective study of 399 sera, the Now Malaria rapid test was compared with
the quantitative buffy coat (QBC) test and microbiological examination of thin blood films. Compared
with the QBC test and thin blood films, the Now Malaria test had sensitivity and specificity values of
96.4% and 97%, respectively, for the detection of pure P. falciparum infection. A negative predictive
value of 99.4% allows this test to be included in diagnostic strategies for patients presenting with clinical
suspicion of malaria. Two false-negative results were associated with low levels of parasitaemia in the
specimens. Thus, use of the Now Malaria test alone to detect P. falciparum infection in non-endemic
countries could lead to misdiagnosis of malaria. This rapid diagnostic test should therefore be
performed in association with another prompt traditional method such as examination of thin blood
films.
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INTRODUCTION
Malaria is endemic in 91 countries around the
world and is responsible for approximately two
million deaths annually [1]. Every year, nearly 50
million people travel from the industrialised
world to malaria-endemic areas, and these num-
bers have increased annually in recent years [2].
Among three million people travelling annually
from France to malaria-endemic areas, 5000–8000
will catch malaria, and up to 20 may die because of
Plasmodium falciparum infection [3]. The high risk
of death in cases of untreated malaria requires that
diagnosis is prompt and accurate, and available
24 h a day for patients admitted to the emergency
unit [4]. A laboratory can use one or several
techniques in order to reach a positive diagnosis of
imported malaria, identify the parasite species, and
estimate the degree of parasitaemia [5]. Traditional
methods use stained blood films (i.e., thick or thin
blood films) [6], with many hospital laboratories
using a thin blood smear stained with Giemsa,
combined with microscopic detection of parasites
using fluorescent dye (acridine orange) in the
centrifugal quantitative buffy coat test (QBC test;
Becton Dickinson, Le Pont de Claix, France) [7,8].
These tests are not easy to perform for an inexperi-
enced microscopist [6]. Similarly, although
PCR-based assays are the most sensitive and
specific methods for detecting malarial parasites,
these assays cannot be performed routinely to
diagnose malaria because of the cost and the time
required [9].
Several new rapid diagnostic tests have been
developed, including immunochromatographic
dipstick assays, which detect malaria antigens in
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whole blood, and which have been evaluated in
both endemic and non-endemic areas [10]. The
antigens detected include those for histidine-rich
protein-2 (HRP-2), which is a P. falciparum-specific
antigen (ParaSight F (no longer marketed); Becton
Dickinson), and for Plasmodium aldolase, which is
a pan-specific antigen, the detection of which is
combined with detection of the HRP-2 P. falcipa-
rum-specific antigen in the Now Malaria dipstick
test (Binax, Portland, ME, USA) [11–13]. A third
antigen, that for Plasmodium lactate dehydroge-
nase, has been used in an immunochromato-
graphic test (OptiMAL; Flow Inc., Portland, OR,
USA) to detect Plasmodium in blood specimens [6].
In the present study, all results concerning trav-
ellers returning from malaria-endemic areas with
suspected malaria were analysed retrospectively
for a 2-year period. To the best of our knowledge,
this study is the first comparison in non-endemic
countries of results obtained by the Now Malaria
test with those obtained by examination of a thin
blood film and the QBC test [10].
MATERIALS AND METHODS
Patients
The study analysed 413 patients presenting to the Grenoble
teaching hospital between April 2002 and April 2004 with a
clinical history compatible with a diagnosis of malaria.
Specimens from other laboratories or hospitals were excluded
from this retrospective study because of the heterogeneity of
the samples submitted and the lack of clinical history con-
cerning each patient.
Microscopic analysis
Thin blood smears were prepared from 5 mL of venous
whole blood collected in an EDTA tube and then stained
with Giemsa 10% w ⁄v solution. In daily practice, as patients
presented, three expert microscopists (a medical biologist, a
technician and an intern) examined each specimen system-
atically at ·1000 magnification for 20 min, with c. 10 000 red
blood cells (RBCs) being examined before the test was
considered to be negative. The density of parasites was
determined by calculating the percentage of parasitised
erythrocytes over 50 consecutive fields, representing c.
10 000 RBCs [10]. Parasitaemia may be expressed as a
percentage of RBCs infected, or as the number of parasites
present in 1 lL of blood. Since 1 lL of blood contains
5 · 106 RBCs, a 1% parasitaemia represents 50 000 para-
sites ⁄ lL [6].
QBC test
The centrifugal QBC assay is a fluorescent microscopic method
that uses acridine orange to stain the nucleic acid of cells and
parasite nuclei [6]. In brief, a whole blood sample is mixed
with acridine orange, and used to coat a capillary tube,
centrifugation of which allows the parasite to be viewed inside
RBCs with a fluorescence microscope [8].
Now Malaria assay
The same sample of whole blood that was used to prepare
thin blood films was also used for the Now Malaria assay.
The test is an immunochromatographic assay that uses two
antibodies which have been immobilised across a test strip
[10]; one antibody is specific for the HRP-2 antigen of
P. falciparum, while the other is specific for an antigen that is
common to all species of Plasmodium. The QBC method and
thin blood films are used systematically in the Grenoble
teaching hospital to diagnose malaria, and these two
methods were used as the reference standard for compar-
ative purposes.
Statistical analysis
Samples were classified as true-positive (TP), true-negative
(TN), false-positive (FP) or false-negative (FN) by comparison
with a reference standard. Sensitivity (TP ⁄TP + FN) and
specificity (TN ⁄TN + FP), as well as positive (TP ⁄TP + FP)
and negative (TN ⁄TN + FN) predictive values, for the Now
Malaria test were then calculated.
RESULTS
During the study period, 413 patients presented
with a clinical suspicion of malaria and a history of
travel to a malaria-endemic country. Of those who
were infected with malaria, the ratio of male to
female patients was 1.6, and there was a mean age
of 32.2 (± 16.5) years (range, 3–66 years). Areas
visited were mostly sub-Saharan Africa (95.4%),
but Asia (1.5%) and Latin America (3.1%) were
also visited. More than half (61.5%) of the cases
were diagnosed in the emergency department,
often during the night.
In total, 535 specimens were collected, of which
399 (75%) were examined by thin blood films and
QBC tests (forming the reference standard) and
Now Malaria tests. Of the 399 specimens exam-
ined, 311 were negative by all three methods, and
65 were positive by all three methods (53 for
P. falciparum, eight for Plasmodium ovale, three for
Plasmodium vivax and one for Plasmodium mala-
riae). However, 18 samples gave discrepant
results, comprising ten samples that were positive
for P. falciparum by the Now Malaria assay, but
negative by thin blood films and the QBC test,
and eight samples that were negative by the Now
Malaria assay, but positive (two for P. falciparum,
five for P. ovale and one for P. vivax) by thin blood
films and the QBC test (Table 1).
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Among the five remaining samples, there were
three P. falciparum–P. ovale mixed infections, two
with no distinction between the species by the
Now Malaria assay (both lines were positive), and
one that was positive only for the HRP-2
P. falciparum-specific line. One sample was hae-
molysed and was negative by the Now Malaria
assay; this sample could not be examined by
microscopy. The final sample could not be inter-
preted with the Now Malaria assay, as the
dipstick control line was not present, even after
multiple assays performed by several experienced
technicians with different batches of Now Malaria
kits.
When compared with the results of QBC tests
and thin blood films, the Now Malaria assay had a
sensitivity of 96.4% and a specificity of 97% for
the detection of pure P. falciparum malaria
(Table 2). The test also had a sensitivity of 66.7%
and a specificity of 100% for non-P. falciparum
malaria. Moreover, the detection sensitivity for
P. falciparum was 100% if only samples con-
taining > 500 parasites ⁄lL (0.01% parasitaemia)
were considered. Positive and negative predictive
values for the diagnosis of P. falciparum malaria
were 84% and 99.4%, respectively, and those
for diagnosis of non-P. falciparum malaria were
100% and 98.2%, respectively. These predictive
values should be interpreted in terms of the
prevalence of P. falciparum and non-P. falciparum
malaria in the patients studied (12.3% and 4.1%,
respectively).
DISCUSSION
This report describes the usefulness of the Now
Malaria assay for the diagnosis of malaria in
returned travellers. Each year, the teaching hos-
pital in Grenoble receives samples from c. 200
patients with a history of recent travel to malaria-
endemic areas and clinical signs compatible with
Plasmodium infection, with a mean of 35 cases of
malaria diagnosed annually. The number of
people visiting malaria-endemic countries is
increasing on an annual basis, so the number of
cases of malaria diagnosed upon their return
should also be expected to increase [2]. In non-
endemic countries, lack of experience could lead
to missed diagnoses of malaria [4], thereby
increasing the risk of severe infection [1]. In
contrast, the requirement in endemic countries is
for tests that are easy to perform and interpret,
particularly in remote areas [10]. For these rea-
sons, it is interesting to evaluate new non-micro-
scopic rapid diagnostic tests. According to WHO
recommendations, new assays should have a
sensitivity of > 95% compared with the standard
of microscopy [5].
As reported previously, the Now Malaria assay
is able to detect P. falciparum and non-P. falciparum
antigens with different sensitivities and specifici-
ties [14–20]. These results should be interpreted
with regard to the reference used and should be
compared carefully because of the heterogeneity
of the study designs (prospective or retrospective)
and the pre-analytical phase (e.g., whole blood
sample conservation, test-kit transportation and
storage). Detection of P. falciparum has shown a
range of sensitivities, from 68.4% to 100%,
whereas the sensitivity for detection of non-
P. falciparum parasites ranges from 39.3% to
84.7% [14–20]. Preliminary results from a com-
parison of the Now Malaria and OptiMAL IT
Table 1. Comparison of the results of the Now Malaria
assay with the reference standard of combined thin blood
film and quantitative buffy coat (QBC) assay
Now Malaria
assay results Total
Reference standard (thin blood film
and QBC test)
P. f. P. o. P. v. P. m.
Mixed
P. f. + P. o. Negative
T1 line +
T2 line +
36 32 1 0 0 2 1
T1 line +
T2 line 0
30 21 0 0 0 1 8
T1 line 0
T2 line +
12 0 8 3 1 0 0
T1 line 0
T2 line 0
319 2 5 1 0 0 311
Total 397a 55 14 4 1 3 320
P. f., P. falciparum; P. o., P. ovale; P. v., P. vivax; P. m., P. malariae.
T1, line where specific antibodies for histidine-rich protein II (HRP-2) antigen of P. f.
are immobilised; T2, line where specific antibodies for a common antigen of P. f., P.
o., P. v. and P. m. are immobilised.
aThere were two additional samples, one of which haemolysed and could not be
examined by microscopy, and one for which the Now Malaria assay could not be
interpreted (see main text).
Table 2. Performance characteristics of the Now Malaria
assay compared to the reference standard of combined thin


















P.f. 96.4 97 84 99.4
Non-P.f. 66.7 100 100 98.2
PPV, positive predictive value; NPV, negative predictive value; P. f., Plasmodium
falciparum.
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assays with QBC tests and thin blood films
indicated that the sensitivity and specificity of
the Now Malaria assay for Plasmodium spp. were
96.3% and 98.8%, respectively [21]. In the present
study, the sensitivity and specificity of the Now
Malaria assay for detection of P. falciparum infec-
tion compared with microscopic methods were
> 95%, suggesting that this test could improve
accuracy in malaria diagnosis [22], although
perhaps performing less well than some other
traditional methods, such as thick blood films
(capable of detecting 0.001% of RBCs infected, or
50 parasites ⁄ lL, when used by experienced micro-
scopists) [6]. This could explain why two false-
negative results were obtained with the Now
Malaria assay for two P. falciparum infections with
a very low level of parasitaemia.
All discrepant positive results for P. falciparum
in the present study with the Now Malaria assay
could be explained by a recent malaria attack,
treated or untreated. Circulating HRP-2 antigens
can persist for weeks following parasitaemia [10].
Indeed, HRP-2 is a protein of P. falciparum that
can be detected as a result of circulating non-
viable parasites, whereas Plasmodium lactate de-
hydrogenase, the antibody for which is also used
in dipstick tests for rapid diagnosis of malaria, is
produced only by viable parasites and is detected
by rapid diagnostic tests earlier than HRP-2 [10].
Since the discrepant positive results obtained in
the present study were correlated with the occur-
rence of a recent malaria attack, other possible
causes of false-positive results (e.g., rheumatoid
factor) need not be considered. The possibility
that the IgM subtypes used in the Now Malaria
assay are less reactive with rheumatoid factor
than the IgG subtypes used in some other dipstick
tests has been discussed previously [22,23]. With
respect to non-P. falciparum infection, the sensi-
tivity and specificity results were in agreement
with those reported in previous studies [14–20].
The lack of sensitivity could be explained by the
weaker affinity for the malaria pan-specific anti-
gen (aldolase) than for HRP-2 antigen [10].
In conclusion, the Now Malaria rapid diagnos-
tic test enables a prompt positive diagnosis of
malaria with high specificity. However, occasional
false-negative results mean that there is a risk of
misdiagnosing malaria caused by P. falciparum.
For this reason, the test cannot be recommended
without also recommending confirmation of a
negative result by a traditional microscopic
method. Nevertheless, if the clinical history of
the patient is taken into account, the good negative
predictive value permits this test to be included as
part of a comprehensive diagnostic strategy.
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